更多...
收起
This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
[中文简述(自动翻译):]  该基因被确定为是在以高频率的大量癌症中突变的肿瘤抑制。由该基因编码的蛋白质是一个磷脂酰肌醇-3,4,5-三磷酸酯-3-磷酸酶。它包含象域的张力蛋白以及类似于双重特异性蛋白酪氨酸磷酸酶的催化??结构域。不像一般的蛋白酪氨酸磷酸酶的,该蛋白质优选脱磷酸化的磷酸肌醇底物。它负面AKT / PKB信号传导途径负调节细胞和用作抑癌磷脂酰-3,4,5-三磷酸酯的细胞内水平调节。使用非规范(CUG)上游起始位点的产生可启动翻译用亮氨酸较长同种型,并且被认为与线粒体内膜优先相关联。这不再亚型可能有助于调节线粒体能量代谢。该基因的假基因是在9号染色体可变剪接发现和使用多个翻译起始密码子在多个成绩单结果变种编码不同亚型。 [由RefSeq的,2015年2月提供]
PTEN基因(以及对应的蛋白质)的细胞分布位置:
PTEN基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
MACROCEPHALY/AUTISM SYNDROME | 0.56 | 1 | 9 | CLINVAR_CTD_human_MGD_ORPHANET_UNIPROT |
Hamartoma Syndrome, Multiple | 0.521446 | 208 | 1 | BeFree_CTD_human_GAD_LHGDN_MGD_ORPHANET_UNIPROT |
Squamous cell carcinoma of the head and neck | 0.482985861 | 12 | 1 | BeFree_CLINVAR_CTD_human_ORPHANET_UNIPROT |
Bannayan-Riley-Ruvalcaba Syndrome | 0.454386419 | 54 | 8 | BeFree_CLINVAR_MGD_ORPHANET_UNIPROT |
Endometrial Carcinoma | 0.358197359 | 133 | 2 | BeFree_CLINVAR_GAD_MGD_UNIPROT |
melanoma | 0.272069867 | 80 | 5 | BeFree_CLINVAR_CTD_human_LHGDN |
Malignant neoplasm of prostate | 0.263876054 | 185 | 0 | BeFree_GAD_MGD_UNIPROT |
Meningioma | 0.245819831 | 7 | 1 | BeFree_CLINVAR_CTD_human_GAD |
Proteus Syndrome | 0.245167327 | 12 | 0 | BeFree_CTD_human_LHGDN_ORPHANET |
Lhermitte-Duclos disease | 0.243257302 | 12 | 3 | BeFree_CLINVAR_ORPHANET |
Proteus-Like Syndrome (disorder) | 0.240814326 | 3 | 2 | BeFree_CLINVAR_ORPHANET |
GLIOMA SUSCEPTIBILITY 2 | 0.24 | 1 | 1 | CLINVAR_UNIPROT |
Autistic Disorder | 0.219802782 | 21 | 0 | BeFree_CTD_human_GAD_LHGDN_MGD |
Insulin Resistance | 0.2 | 2 | 0 | CTD_human_RGD |
Reperfusion Injury | 0.2 | 2 | 0 | CTD_human_RGD |
Glioma | 0.18229318 | 119 | 2 | BeFree_CTD_human_GAD_LHGDN |
Prostatic Neoplasms | 0.179287082 | 49 | 0 | BeFree_CTD_human_GAD_LHGDN |
Endometrial Neoplasms | 0.170975954 | 28 | 0 | BeFree_CTD_human_GAD_LHGDN |
Mammary Neoplasms | 0.162755415 | 34 | 0 | BeFree_CTD_human_LHGDN |
Neoplasm Metastasis | 0.158041588 | 102 | 0 | BeFree_CTD_human_LHGDN |
Adenocarcinoma | 0.156115208 | 41 | 0 | BeFree_CTD_human_GAD_LHGDN |
Renal Cell Carcinoma | 0.135240471 | 21 | 1 | BeFree_CTD_human_LHGDN |
Lung Neoplasms | 0.129258818 | 8 | 0 | BeFree_CTD_human_LHGDN |
leukemia | 0.129248887 | 17 | 0 | BeFree_CTD_human_LHGDN |
Pancreatic Neoplasm | 0.127815732 | 4 | 0 | CTD_human_GAD_LHGDN |
ovarian neoplasm | 0.12617715 | 7 | 0 | BeFree_CTD_human_GAD_LHGDN |
PTEN Hamartoma Tumor Syndrome | 0.125971721 | 22 | 10 | BeFree_CLINVAR |
Lymphoma | 0.125438769 | 12 | 0 | BeFree_CTD_human_LHGDN |
Juvenile polyposis syndrome | 0.123800186 | 14 | 0 | BeFree_CTD_human |
Nasopharyngeal carcinoma | 0.122985861 | 12 | 0 | BeFree_CTD_human |
Disease Progression | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
Endometrial Hyperplasia | 0.122442977 | 10 | 0 | BeFree_CTD_human |
Craniofacial Abnormalities | 0.122367032 | 6 | 0 | CTD_human_GAD |
Small cell carcinoma of lung | 0.121900093 | 8 | 1 | BeFree_CTD_human |
Neoplastic Syndromes, Hereditary | 0.121628651 | 6 | 97 | BeFree_CLINVAR |
Lipomatosis | 0.121085767 | 4 | 0 | BeFree_CTD_human |
Prostatic Intraepithelial Neoplasias | 0.121085767 | 6 | 0 | BeFree_CTD_human |
Lipoma | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Hereditary Breast and Ovarian Cancer Syndrome | 0.120542884 | 2 | 0 | BeFree_ORPHANET |
Asthma | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Developmental Disabilities | 0.120271442 | 4 | 0 | BeFree_CTD_human |
Adenoid Cystic Carcinoma | 0.120271442 | 2 | 0 | BeFree_CTD_human |
IGA Glomerulonephritis | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Hemangioma | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Sezary Syndrome | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Polydactyly | 0.120271442 | 1 | 0 | BeFree_CTD_human |
Vater Association With Macrocephaly And Ventriculomegaly | 0.120271442 | 1 | 1 | BeFree_CLINVAR |
Anisometropia | 0.12 | 1 | 0 | CTD_human |
Hypertensive disease | 0.12 | 1 | 0 | CTD_human |
Language Development Disorders | 0.12 | 1 | 0 | CTD_human |
Acute Megakaryocytic Leukemias | 0.12 | 0 | 1 | CLINVAR |
Long QT Syndrome | 0.12 | 1 | 0 | CTD_human |
Motor Skills Disorders | 0.12 | 1 | 0 | CTD_human |
Myocardial Reperfusion Injury | 0.12 | 1 | 0 | CTD_human |
Neoplasm Invasiveness | 0.12 | 1 | 0 | CTD_human |
Dermatologic disorders | 0.12 | 1 | 0 | CTD_human |
LEOPARD Syndrome | 0.12 | 1 | 0 | CTD_human |
Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) | 0.12 | 0 | 0 | ORPHANET |
Familial meningioma | 0.12 | 0 | 0 | CTD_human |
Mediastinal Germ Cell Tumor | 0.12 | 0 | 1 | CLINVAR |
MELANOMA, CUTANEOUS MALIGNANT, 1 | 0.12 | 0 | 0 | CTD_human |
VACTERL Association With Hydrocephalus | 0.12 | 1 | 0 | CTD_human |
Pten Hamartoma Tumor Syndrome With Granular Cell Tumor | 0.12 | 0 | 0 | CLINVAR |
Chromosome 10q23 Deletion Syndrome | 0.12 | 0 | 0 | ORPHANET |
Thyroid cancer, follicular | 0.12 | 0 | 0 | CTD_human |
Intellectual Disability | 0.12 | 5 | 0 | CTD_human |
Liver carcinoma | 0.106108077 | 48 | 0 | BeFree_LHGDN_MGD |
Malignant neoplasm of urinary bladder | 0.086710102 | 17 | 0 | BeFree_GAD_MGD |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.08408156 | 6 | 0 | BeFree_LHGDN_MGD |
Diabetes Mellitus | 0.081357209 | 6 | 0 | BeFree_RGD |
Diabetic Nephropathy | 0.080271442 | 2 | 0 | BeFree_RGD |
Fatty Liver | 0.080271442 | 2 | 0 | BeFree_RGD |
Transient Ischemic Attack | 0.08 | 1 | 0 | RGD |
Cardiomegaly | 0.08 | 1 | 0 | RGD |
Hyperinsulinism | 0.08 | 1 | 0 | RGD |
Hypertension, Portal | 0.08 | 1 | 0 | RGD |
Persistent Fetal Circulation Syndrome | 0.08 | 0 | 0 | MGD |
Stomach Diseases | 0.08 | 1 | 0 | RGD |
Left Ventricular Hypertrophy | 0.08 | 1 | 0 | RGD |
Substance-Related Disorders | 0.08 | 1 | 0 | RGD |
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1 | 0.08 | 0 | 0 | MGD |
Carcinogenesis | 0.052659723 | 194 | 0 | BeFree |
Malignant neoplasm of breast | 0.050651348 | 144 | 5 | BeFree_GAD |
Glioblastoma | 0.049376133 | 126 | 0 | BeFree_GAD_LHGDN |
Prostate carcinoma | 0.048045211 | 177 | 0 | BeFree |
Breast Carcinoma | 0.036101769 | 133 | 5 | BeFree |
Stomach Neoplasms | 0.027157626 | 11 | 0 | BeFree_GAD_LHGDN |
Squamous cell carcinoma | 0.019964603 | 29 | 0 | BeFree_GAD_LHGDN |
Hamartoma | 0.018206468 | 49 | 0 | BeFree_LHGDN |
Colorectal Cancer | 0.016482009 | 53 | 0 | BeFree_GAD |
Malignant neoplasm of lung | 0.016254175 | 29 | 0 | BeFree_GAD |
Thyroid Neoplasm | 0.016240362 | 24 | 0 | BeFree_GAD_LHGDN |
Brain Neoplasms | 0.016078541 | 17 | 0 | BeFree_GAD_LHGDN |
Malignant neoplasm of endometrium | 0.014929303 | 55 | 0 | BeFree |
Non-Small Cell Lung Carcinoma | 0.014929303 | 55 | 0 | BeFree |
Uterine Corpus Cancer | 0.014929303 | 55 | 0 | BeFree |
Malignant neoplasm of ovary | 0.013963088 | 36 | 0 | BeFree_GAD |
Colorectal Carcinoma | 0.013300652 | 49 | 0 | BeFree |
Carcinoma, Endometrioid | 0.012887252 | 22 | 0 | BeFree_GAD_LHGDN |
Stomach Carcinoma | 0.012757768 | 47 | 0 | BeFree |
Endometriosis | 0.012625741 | 12 | 0 | BeFree_GAD_LHGDN |
Astrocytoma | 0.011691864 | 23 | 0 | BeFree_LHGDN |
Malignant neoplasm of stomach | 0.011400559 | 42 | 0 | BeFree |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.011172724 | 16 | 0 | BeFree_GAD |
Ovarian Carcinoma | 0.011129117 | 41 | 0 | BeFree |
Thyroid carcinoma | 0.008957582 | 33 | 0 | BeFree |
Bladder Neoplasm | 0.008715934 | 5 | 0 | BeFree_LHGDN |
Tumor Progression | 0.00868614 | 32 | 0 | BeFree |
Colorectal Neoplasms | 0.008444493 | 4 | 0 | BeFree_LHGDN |
Hyperplasia | 0.008173051 | 3 | 0 | LHGDN |
Malignant neoplasm of thyroid | 0.007328931 | 27 | 0 | BeFree |
Macrocephaly | 0.006786047 | 25 | 0 | BeFree |
Carcinoma of lung | 0.006786047 | 25 | 0 | BeFree |
Hepatitis B | 0.006534468 | 5 | 0 | BeFree_LHGDN |
Glioblastoma Multiforme | 0.00643866 | 15 | 0 | BeFree_GAD |
Sarcoma | 0.005981653 | 12 | 0 | BeFree_LHGDN |
Diabetes Mellitus, Non-Insulin-Dependent | 0.005819831 | 4 | 0 | BeFree_GAD |
Leukemia, T-Cell | 0.005720142 | 2 | 0 | BeFree_LHGDN |
Malignant tumor of colon | 0.005700279 | 21 | 0 | BeFree |
Colon Carcinoma | 0.005428837 | 20 | 0 | BeFree |
Epithelial ovarian cancer | 0.005081451 | 11 | 1 | BeFree_GAD |
Malignant Glioma | 0.004885954 | 18 | 0 | BeFree |
Colorectal cancer metastatic | 0.004885954 | 18 | 1 | BeFree |
Anaplastic astrocytoma | 0.004538567 | 8 | 0 | BeFree_GAD |
Malignant neoplasm of esophagus | 0.004538567 | 8 | 0 | BeFree_GAD |
Medulloblastoma | 0.004353001 | 6 | 0 | BeFree_LHGDN |
Malignant neoplasm of pancreas | 0.00434307 | 16 | 0 | BeFree |
Carcinoma of bladder | 0.00434307 | 16 | 0 | BeFree |
Esophageal Neoplasms | 0.004267125 | 8 | 0 | BeFree_GAD |
oligodendroglioma | 0.00408156 | 6 | 0 | BeFree_LHGDN |
Cervix carcinoma | 0.004071628 | 15 | 0 | BeFree |
Hemangiosarcoma | 0.003810118 | 4 | 0 | BeFree_LHGDN |
Adenocarcinoma, Clear Cell | 0.003810118 | 4 | 0 | BeFree_LHGDN |
Malignant tumor of cervix | 0.003800186 | 14 | 0 | BeFree |
Pancreatic carcinoma | 0.003800186 | 14 | 0 | BeFree |
Mycosis Fungoides | 0.003538676 | 4 | 0 | BeFree_LHGDN |
Neuroblastoma | 0.003528744 | 13 | 0 | BeFree |
Squamous cell carcinoma of esophagus | 0.003528744 | 13 | 0 | BeFree |
Carcinoma, Transitional Cell | 0.003267234 | 2 | 0 | BeFree_LHGDN |
B-Cell Lymphomas | 0.003267234 | 3 | 0 | BeFree_LHGDN |
Ductal Carcinoma | 0.003267234 | 3 | 0 | BeFree_LHGDN |
Follicular thyroid carcinoma | 0.003257302 | 12 | 2 | BeFree |
Central neuroblastoma | 0.003257302 | 12 | 0 | BeFree |
Acoustic Neuroma | 0.003181358 | 3 | 0 | BeFree_GAD |
Retinoblastoma | 0.003181358 | 4 | 0 | BeFree_GAD |
Dysgerminoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Fibroid Tumor | 0.002995792 | 2 | 0 | BeFree_LHGDN |
synovial sarcoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Granular cell tumor | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Secondary malignant neoplasm of lymph node | 0.002985861 | 11 | 0 | BeFree |
Malignant neoplasm of kidney | 0.002985861 | 11 | 0 | BeFree |
Hemorrhage | 0.00272435 | 1 | 0 | LHGDN |
Inflammation | 0.00272435 | 1 | 0 | LHGDN |
Lung diseases | 0.00272435 | 1 | 0 | LHGDN |
Prostatic Diseases | 0.00272435 | 1 | 0 | LHGDN |
Sprains and Strains | 0.00272435 | 1 | 0 | LHGDN |
Ki-1+ Anaplastic Large Cell Lymphoma | 0.00272435 | 1 | 0 | LHGDN |
Sarcoma, Clear Cell | 0.00272435 | 1 | 0 | LHGDN |
Multiple polyps | 0.002714419 | 10 | 0 | BeFree |
Autism Spectrum Disorders | 0.002714419 | 10 | 0 | BeFree |
Colonic Neoplasms | 0.002638474 | 2 | 0 | BeFree_GAD |
Chronic Obstructive Airway Disease | 0.002638474 | 1 | 0 | BeFree_GAD |
Lupus Erythematosus, Systemic | 0.002638474 | 2 | 0 | BeFree_GAD |
Nicotine Dependence | 0.002638474 | 1 | 0 | BeFree_GAD |
Ovarian Failure, Premature | 0.002638474 | 1 | 0 | BeFree_GAD |
Malignant neoplasm of brain | 0.002638474 | 2 | 0 | BeFree_GAD |
Papillary adenocarcinoma | 0.002367032 | 1 | 0 | GAD |
Narcolepsy | 0.002367032 | 1 | 0 | GAD |
Neoplasm Recurrence, Local | 0.002367032 | 1 | 0 | GAD |
Neoplasms, Glandular and Epithelial | 0.002367032 | 1 | 0 | GAD |
Rectal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Skin Neoplasms | 0.002367032 | 1 | 0 | GAD |
Retinal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Microsatellite Instability | 0.002367032 | 1 | 0 | GAD |
Multiple Myeloma | 0.002171535 | 8 | 0 | BeFree |
Parkinson Disease | 0.002171535 | 8 | 0 | BeFree |
Esophageal carcinoma | 0.002171535 | 8 | 0 | BeFree |
Hereditary Nonpolyposis Colorectal Cancer | 0.002171535 | 8 | 0 | BeFree |
Renal carcinoma | 0.002171535 | 8 | 0 | BeFree |
Osteosarcoma | 0.001900093 | 7 | 0 | BeFree |
Peutz-Jeghers Syndrome | 0.001900093 | 7 | 0 | BeFree |
polyps | 0.001900093 | 7 | 0 | BeFree |
Metastatic malignant neoplasm to brain | 0.001900093 | 7 | 0 | BeFree |
Parkinsonian Disorders | 0.001900093 | 7 | 1 | BeFree |
Metastatic melanoma | 0.001900093 | 7 | 1 | BeFree |
Solid tumour | 0.001900093 | 7 | 0 | BeFree |
Malignant neoplasm of liver | 0.001900093 | 7 | 0 | BeFree |
Hereditary Malignant Neoplasm | 0.001900093 | 7 | 0 | BeFree |
Atrial Septal Defects | 0.001628651 | 6 | 0 | BeFree |
Myeloid Leukemia, Chronic | 0.001628651 | 6 | 0 | BeFree |
Monosomy | 0.001628651 | 6 | 0 | BeFree |
Myocardial Infarction | 0.001628651 | 6 | 0 | BeFree |
Papillary thyroid carcinoma | 0.001628651 | 6 | 0 | BeFree |
Carcinoma breast stage IV | 0.001628651 | 6 | 0 | BeFree |
Gastric Adenocarcinoma | 0.001628651 | 6 | 0 | BeFree |
Conventional (Clear Cell) Renal Cell Carcinoma | 0.001628651 | 6 | 0 | BeFree |
Anaplastic Oligodendroglioma | 0.001628651 | 6 | 0 | BeFree |
Osteosarcoma of bone | 0.001628651 | 6 | 0 | BeFree |
Adenocarcinoma, Endometrioid | 0.001628651 | 6 | 0 | BeFree |
Rectal Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Noninfiltrating Intraductal Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Diabetes | 0.001357209 | 5 | 0 | BeFree |
Chronic Lymphocytic Leukemia | 0.001357209 | 5 | 0 | BeFree |
Acute lymphocytic leukemia | 0.001357209 | 5 | 0 | BeFree |
Liver neoplasms | 0.001357209 | 5 | 0 | BeFree |
Tuberous Sclerosis | 0.001357209 | 5 | 0 | BeFree |
Adenocarcinoma of lung (disorder) | 0.001357209 | 5 | 3 | BeFree |
Liver and Intrahepatic Biliary Tract Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Breast Cancer, Familial | 0.001357209 | 5 | 0 | BeFree |
Endometrioid carcinoma ovary | 0.001357209 | 5 | 0 | BeFree |
Developmental delay (disorder) | 0.001357209 | 5 | 0 | BeFree |
Well Differentiated Oligodendroglioma | 0.001357209 | 5 | 0 | BeFree |
Metastatic Prostate Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Endometrial adenocarcinoma | 0.001357209 | 5 | 0 | BeFree |
Sporadic Breast Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Xenograft Model | 0.001357209 | 5 | 0 | BeFree |
Non-Neoplastic Disorder | 0.001357209 | 5 | 0 | BeFree |
Triple Negative Breast Neoplasms | 0.001357209 | 5 | 0 | BeFree |
Congenital Abnormality | 0.001085767 | 4 | 0 | BeFree |
Adenoma | 0.001085767 | 4 | 0 | BeFree |
Malignant neoplasm of skin | 0.001085767 | 4 | 0 | BeFree |
Epilepsy | 0.001085767 | 4 | 0 | BeFree |
Li-Fraumeni Syndrome | 0.001085767 | 4 | 0 | BeFree |
Cutaneous Melanoma | 0.001085767 | 4 | 0 | BeFree |
Follicular adenoma | 0.001085767 | 4 | 0 | BeFree |
Undifferentiated carcinoma | 0.001085767 | 4 | 0 | BeFree |
Anaplastic thyroid carcinoma | 0.001085767 | 4 | 1 | BeFree |
Turcot syndrome (disorder) | 0.001085767 | 4 | 0 | BeFree |
Malignant Peripheral Nerve Sheath Tumor | 0.001085767 | 4 | 0 | BeFree |
Tumor Angiogenesis | 0.001085767 | 4 | 0 | BeFree |
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1 | 0.001085767 | 4 | 0 | BeFree |
Benign symmetrical lipomatosis | 0.001085767 | 4 | 0 | BeFree |
Chordoma | 0.000814326 | 3 | 0 | BeFree |
Cyst | 0.000814326 | 3 | 0 | BeFree |
Von Hippel-Lindau Syndrome | 0.000814326 | 3 | 0 | BeFree |
Kidney Neoplasm | 0.000814326 | 3 | 0 | BeFree |
leiomyosarcoma | 0.000814326 | 3 | 0 | BeFree |
Leukemia, Myelocytic, Acute | 0.000814326 | 3 | 0 | BeFree |
Liver diseases | 0.000814326 | 3 | 0 | BeFree |
Mental Retardation | 0.000814326 | 3 | 0 | BeFree |
Neurofibromatosis 1 | 0.000814326 | 3 | 0 | BeFree |
Obesity | 0.000814326 | 3 | 0 | BeFree |
Ovarian Cysts | 0.000814326 | 3 | 0 | BeFree |
Papilloma | 0.000814326 | 3 | 0 | BeFree |
Adenomatous Polyposis Coli | 0.000814326 | 3 | 0 | BeFree |
Precancerous Conditions | 0.000814326 | 3 | 0 | BeFree |
Retroviridae Infections | 0.000814326 | 3 | 0 | BeFree |
Xeroderma Pigmentosum | 0.000814326 | 3 | 0 | BeFree |
Benign Neoplasm | 0.000814326 | 3 | 0 | BeFree |
Thyroid Gland Follicular Adenoma | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of mouth | 0.000814326 | 3 | 0 | BeFree |
Secondary malignant neoplasm of bone | 0.000814326 | 3 | 0 | BeFree |
Cholangiocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Cystadenocarcinoma, Serous | 0.000814326 | 3 | 0 | BeFree |
Uveal melanoma | 0.000814326 | 3 | 0 | BeFree |
Juvenile polyp | 0.000814326 | 3 | 0 | BeFree |
Gastrointestinal Stromal Tumors | 0.000814326 | 3 | 0 | BeFree |
Carcinoma, Small Cell | 0.000814326 | 3 | 1 | BeFree |
Inflammatory Breast Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Laryngeal Squamous Cell Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Hamartomatous polyp | 0.000814326 | 3 | 0 | BeFree |
Pilocytic Astrocytoma | 0.000814326 | 3 | 0 | BeFree |
Atypical Endometrial Hyperplasia | 0.000814326 | 3 | 0 | BeFree |
Leukemogenesis | 0.000814326 | 3 | 0 | BeFree |
Chromosome 10, monosomy 10q | 0.000814326 | 3 | 0 | BeFree |
Invasive breast carcinoma | 0.000814326 | 3 | 0 | BeFree |
Hormone refractory prostate cancer | 0.000814326 | 3 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Hepatocarcinogenesis | 0.000814326 | 3 | 0 | BeFree |
Mammary Tumorigenesis | 0.000814326 | 3 | 0 | BeFree |
Secondary Glioblastoma | 0.000814326 | 3 | 0 | BeFree |
Brain Diseases | 0.000542884 | 2 | 0 | BeFree |
Breast Diseases | 0.000542884 | 2 | 0 | BeFree |
Carcinoid Tumor | 0.000542884 | 2 | 0 | BeFree |
Female Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Adenocarcinoma of prostate | 0.000542884 | 2 | 0 | BeFree |
Cerebellar Neoplasms | 0.000542884 | 2 | 0 | BeFree |
Choriocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Congenital chromosomal disease | 0.000542884 | 2 | 0 | BeFree |
Exanthema | 0.000542884 | 2 | 0 | BeFree |
Fibrosarcoma | 0.000542884 | 2 | 0 | BeFree |
Ganglioneuroma | 0.000542884 | 2 | 0 | BeFree |
granulosa cell tumor | 0.000542884 | 2 | 0 | BeFree |
Hydatidiform Mole | 0.000542884 | 2 | 0 | BeFree |
Ischemia | 0.000542884 | 2 | 0 | BeFree |
Kidney Failure, Acute | 0.000542884 | 2 | 0 | BeFree |
Myeloid Leukemia | 0.000542884 | 2 | 0 | BeFree |
Malaria | 0.000542884 | 2 | 0 | BeFree |
Multiple Endocrine Neoplasia Type 2a | 0.000542884 | 2 | 0 | BeFree |
Metabolic Diseases | 0.000542884 | 2 | 0 | BeFree |
Neurilemmoma | 0.000542884 | 2 | 0 | BeFree |
Pituitary Neoplasms | 0.000542884 | 2 | 0 | BeFree |
Protein Deficiency | 0.000542884 | 2 | 0 | BeFree |
Teratoma | 0.000542884 | 2 | 0 | BeFree |
Thyroid Diseases | 0.000542884 | 2 | 0 | BeFree |
Thyroid Nodule | 0.000542884 | 2 | 0 | BeFree |
Attention Deficit Disorder | 0.000542884 | 2 | 0 | BeFree |
Severe Combined Immunodeficiency | 0.000542884 | 2 | 0 | BeFree |
Uterine Cancer | 0.000542884 | 2 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.000542884 | 2 | 0 | BeFree |
Porphyria Cutanea Tarda | 0.000542884 | 2 | 0 | BeFree |
Agenesis of corpus callosum | 0.000542884 | 2 | 0 | BeFree |
Anaplastic carcinoma | 0.000542884 | 2 | 0 | BeFree |
Papillomatosis | 0.000542884 | 2 | 0 | BeFree |
Adenosquamous carcinoma | 0.000542884 | 2 | 0 | BeFree |
Adenomatous Polyps | 0.000542884 | 2 | 0 | BeFree |
Cervical Intraepithelial Neoplasia | 0.000542884 | 2 | 0 | BeFree |
gliosarcoma | 0.000542884 | 2 | 0 | BeFree |
Lip and Oral Cavity Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of female breast | 0.000542884 | 2 | 0 | BeFree |
Neoplasm, Residual | 0.000542884 | 2 | 0 | BeFree |
Multiple tumors | 0.000542884 | 2 | 0 | BeFree |
Acute respiratory failure | 0.000542884 | 2 | 0 | BeFree |
Cervical Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Anaplastic Ependymoma | 0.000542884 | 2 | 0 | BeFree |
bilateral breast cancer | 0.000542884 | 2 | 0 | BeFree |
Benign Meningioma | 0.000542884 | 2 | 0 | BeFree |
Cronkhite-Canada Syndrome | 0.000542884 | 2 | 0 | BeFree |
Carcinoid tumor no ICD-O subtype | 0.000542884 | 2 | 0 | BeFree |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.000542884 | 2 | 0 | BeFree |
Adenocarcinoma of colon | 0.000542884 | 2 | 0 | BeFree |
Secondary malignant neoplasm of prostate | 0.000542884 | 2 | 0 | BeFree |
Squamous cell carcinoma of tongue | 0.000542884 | 2 | 0 | BeFree |
Hematologic Neoplasms | 0.000542884 | 2 | 0 | BeFree |
Carney Complex | 0.000542884 | 2 | 0 | BeFree |
Hemimegalencephaly | 0.000542884 | 2 | 0 | BeFree |
Follicular neoplasm | 0.000542884 | 2 | 0 | BeFree |
Secondary malignant neoplasm of liver | 0.000542884 | 2 | 0 | BeFree |
Recurrent tumor | 0.000542884 | 2 | 0 | BeFree |
Complete hydatidiform mole | 0.000542884 | 2 | 0 | BeFree |
Autosomal Recessive Parkinsonism | 0.000542884 | 2 | 0 | BeFree |
precancerous lesions | 0.000542884 | 2 | 0 | BeFree |
Thyroid hyperplasia | 0.000542884 | 2 | 0 | BeFree |
Invasive Ductal Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Attention deficit hyperactivity disorder | 0.000542884 | 2 | 0 | BeFree |
Precursor B-cell lymphoblastic leukemia | 0.000542884 | 2 | 0 | BeFree |
Endometrial intraepithelial neoplasia | 0.000542884 | 2 | 0 | BeFree |
Invasive Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Testicular Germ Cell Tumor | 0.000542884 | 2 | 0 | BeFree |
Epithelioma | 0.000542884 | 2 | 0 | BeFree |
Breast Cancer Model | 0.000542884 | 2 | 0 | BeFree |
Skin Carcinogenesis | 0.000542884 | 2 | 0 | BeFree |
Benign Prostatic Hyperplasia | 0.000542884 | 2 | 0 | BeFree |
Idiopathic Pulmonary Fibrosis | 0.000542884 | 2 | 0 | BeFree |
LATERAL MENINGOCELE SYNDROME | 0.000542884 | 2 | 0 | BeFree |
Congenital vascular anomaly | 0.000542884 | 2 | 0 | BeFree |
HYDATIDIFORM MOLE, RECURRENT, 1 | 0.000542884 | 2 | 0 | BeFree |
Lipomatosis, Multiple | 0.000542884 | 2 | 0 | BeFree |
Amputation Stumps | 0.000271442 | 1 | 0 | BeFree |
Anaplasia | 0.000271442 | 1 | 0 | BeFree |
Anemia | 0.000271442 | 1 | 0 | BeFree |
Aortic Aneurysm | 0.000271442 | 1 | 0 | BeFree |
Congenital arteriovenous malformation | 0.000271442 | 1 | 0 | BeFree |
Arthritis | 0.000271442 | 1 | 0 | BeFree |
Rheumatoid Arthritis | 0.000271442 | 1 | 0 | BeFree |
Autoimmune Diseases | 0.000271442 | 1 | 0 | BeFree |
Mental disorders | 0.000271442 | 1 | 0 | BeFree |
Bladder neck obstruction | 0.000271442 | 1 | 0 | BeFree |
Bronchioloalveolar Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Merkel cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
Mucinous Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Papillary | 0.000271442 | 1 | 0 | BeFree |
Carcinosarcoma | 0.000271442 | 1 | 0 | BeFree |
Cardiomyopathy, Dilated | 0.000271442 | 1 | 0 | BeFree |
Cervical dysplasia | 0.000271442 | 1 | 0 | BeFree |
Uterine Cervical Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Colitis | 0.000271442 | 1 | 0 | BeFree |
Cystadenoma | 0.000271442 | 1 | 0 | BeFree |
Endometritis | 0.000271442 | 1 | 0 | BeFree |
Ependymoma | 0.000271442 | 1 | 0 | BeFree |
Fragile X Syndrome | 0.000271442 | 1 | 0 | BeFree |
Gastrointestinal Diseases | 0.000271442 | 1 | 0 | BeFree |
Gastrointestinal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Cardiac Arrest | 0.000271442 | 1 | 0 | BeFree |
Heart failure | 0.000271442 | 1 | 0 | BeFree |
Congestive heart failure | 0.000271442 | 1 | 0 | BeFree |
Helminthiasis | 0.000271442 | 1 | 0 | BeFree |
Herpes NOS | 0.000271442 | 1 | 0 | BeFree |
HIV Infections | 0.000271442 | 1 | 0 | BeFree |
Hydrocephalus | 0.000271442 | 1 | 0 | BeFree |
Immunologic Deficiency Syndromes | 0.000271442 | 1 | 0 | BeFree |
insulinoma | 0.000271442 | 1 | 0 | BeFree |
Keloid | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Lymphocytic, Acute, L1 | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Plasma Cell | 0.000271442 | 1 | 0 | BeFree |
Adult T-Cell Lymphoma/Leukemia | 0.000271442 | 1 | 0 | BeFree |
Lymphadenitis | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, Follicular | 0.000271442 | 1 | 0 | BeFree |
Primary malignant neoplasm of liver | 0.000271442 | 1 | 0 | BeFree |
Mixed Salivary Gland Tumor | 0.000271442 | 1 | 0 | BeFree |
Muscle hypotonia | 0.000271442 | 1 | 0 | BeFree |
Muscular Dystrophy | 0.000271442 | 1 | 0 | BeFree |
Mycobacterium Infections | 0.000271442 | 1 | 0 | BeFree |
Nephroblastoma | 0.000271442 | 1 | 0 | BeFree |
nervous system disorder | 0.000271442 | 1 | 0 | BeFree |
Ovarian Diseases | 0.000271442 | 1 | 0 | BeFree |
Pancytopenia | 0.000271442 | 1 | 0 | BeFree |
Plasmacytoma | 0.000271442 | 1 | 0 | BeFree |
Rhabdomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
Seizures | 0.000271442 | 1 | 0 | BeFree |
Seminoma | 0.000271442 | 1 | 0 | BeFree |
Skin lesion | 0.000271442 | 1 | 0 | BeFree |
Testicular Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Trisomy | 0.000271442 | 1 | 0 | BeFree |
Uterine Fibroids | 0.000271442 | 1 | 0 | BeFree |
Vascular Diseases | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, T-Cell, Cutaneous | 0.000271442 | 1 | 0 | BeFree |
Polyendocrinopathies, Autoimmune | 0.000271442 | 1 | 0 | BeFree |
Autosomal Recessive Polycystic Kidney Disease | 0.000271442 | 1 | 0 | BeFree |
Burning sensation | 0.000271442 | 1 | 0 | BeFree |
Renal fibrosis | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of testis | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of kidney | 0.000271442 | 1 | 0 | BeFree |
Right Ventricular Hypertrophy | 0.000271442 | 1 | 0 | BeFree |
Germ cell tumor | 0.000271442 | 1 | 0 | BeFree |
Sarcoma, Epithelioid | 0.000271442 | 1 | 0 | BeFree |
Angiomyolipoma | 0.000271442 | 1 | 0 | BeFree |
Rhabdomyosarcoma, Embryonal | 0.000271442 | 1 | 0 | BeFree |
Embryonal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Sebaceous Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Acinar Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Nerve Sheath Tumors | 0.000271442 | 1 | 0 | BeFree |
Plexiform Neurofibroma | 0.000271442 | 1 | 0 | BeFree |
Neuroendocrine Tumors | 0.000271442 | 1 | 0 | BeFree |
Nevi and Melanomas | 0.000271442 | 1 | 0 | BeFree |
Psychiatric symptom | 0.000271442 | 1 | 0 | BeFree |
Neurologic Symptoms | 0.000271442 | 1 | 0 | BeFree |
Cerebral atrophy | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of Male Breast | 0.000271442 | 1 | 0 | BeFree |
Intraductal papilloma of breast | 0.000271442 | 1 | 0 | BeFree |
Teratoma of testis | 0.000271442 | 1 | 0 | BeFree |
bone destruction | 0.000271442 | 1 | 0 | BeFree |
Squamous Papilloma of the Larynx | 0.000271442 | 1 | 0 | BeFree |
Islet Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of male breast | 0.000271442 | 1 | 0 | BeFree |
Simple renal cyst | 0.000271442 | 1 | 0 | BeFree |
Spastic syndrome | 0.000271442 | 1 | 0 | BeFree |
Erythroblastosis | 0.000271442 | 1 | 0 | BeFree |
Shwachman syndrome | 0.000271442 | 1 | 0 | BeFree |
Cancer of Head and Neck | 0.000271442 | 1 | 0 | BeFree |
Invasive Lobular Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
B-cell adult acute lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
Cervical Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Transitional cell carcinoma of bladder | 0.000271442 | 1 | 0 | BeFree |
Acute Undifferentiated Leukemia | 0.000271442 | 1 | 0 | BeFree |
Juvenile Pilocytic Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Congenital hemihypertrophy | 0.000271442 | 1 | 0 | BeFree |
Restenosis | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma in Situ | 0.000271442 | 1 | 0 | BeFree |
Malignant Fibrous Histiocytoma | 0.000271442 | 1 | 0 | BeFree |
Arteriovenous hemangioma | 0.000271442 | 1 | 0 | BeFree |
Gliomatosis cerebri | 0.000271442 | 1 | 0 | BeFree |
Gemistocytic astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Giant Cell Glioblastoma | 0.000271442 | 1 | 0 | BeFree |
Histiocytic sarcoma | 0.000271442 | 1 | 0 | BeFree |
Uterine Corpus Sarcoma | 0.000271442 | 1 | 0 | BeFree |
Gastric Hamartoma | 0.000271442 | 1 | 0 | BeFree |
Atrophy of kidney | 0.000271442 | 1 | 0 | BeFree |
Malignant mesothelioma | 0.000271442 | 1 | 0 | BeFree |
Acral Lentiginous Malignant Melanoma | 0.000271442 | 1 | 0 | BeFree |
Stage 0 Skin Melanoma | 0.000271442 | 1 | 0 | BeFree |
Dysgerminoma of ovary | 0.000271442 | 1 | 0 | BeFree |
Cystadenocarcinoma of kidney | 0.000271442 | 1 | 0 | BeFree |
Multiple malignancy | 0.000271442 | 1 | 0 | BeFree |
Intestinal Cancer | 0.000271442 | 1 | 0 | BeFree |
Disseminated Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Skin Papilloma | 0.000271442 | 1 | 0 | BeFree |
Juvenile Myelomonocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of vulva | 0.000271442 | 1 | 0 | BeFree |
Thrombophilia | 0.000271442 | 1 | 0 | BeFree |
Cortical Dysplasia | 0.000271442 | 1 | 0 | BeFree |
Plasma cell tumor, malignant | 0.000271442 | 1 | 0 | BeFree |
Ewings sarcoma | 0.000271442 | 1 | 0 | BeFree |
Tonsillar Carcinoma | 0.000271442 | 1 | 0 | BeFree |
CARCINOMA OF VULVA | 0.000271442 | 1 | 0 | BeFree |
Refractory cancer | 0.000271442 | 1 | 0 | BeFree |
CNS metastases | 0.000271442 | 1 | 0 | BeFree |
Arteriovenous graft | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm tonsil | 0.000271442 | 1 | 0 | BeFree |
Adult Acute Lymphocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Spots on skin | 0.000271442 | 1 | 0 | BeFree |
Uterine carcinoma | 0.000271442 | 1 | 0 | BeFree |
female breast hyperplasia | 0.000271442 | 1 | 0 | BeFree |
Adenomatous polyp of colon | 0.000271442 | 1 | 0 | BeFree |
Adenoviral infections | 0.000271442 | 1 | 0 | BeFree |
Testicular malignant germ cell tumor | 0.000271442 | 1 | 0 | BeFree |
Endothelial dysfunction | 0.000271442 | 1 | 0 | BeFree |
Philadelphia chromosome positive | 0.000271442 | 1 | 0 | BeFree |
Autistic behavior | 0.000271442 | 1 | 0 | BeFree |
Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Mental deficiency | 0.000271442 | 1 | 0 | BeFree |
Ischemic stroke | 0.000271442 | 1 | 0 | BeFree |
Arthritis, Collagen-Induced | 0.000271442 | 1 | 0 | BeFree |
Small cell carcinoma of esophagus | 0.000271442 | 1 | 0 | BeFree |
Colonic tubulovillous adenoma | 0.000271442 | 1 | 0 | BeFree |
Diffuse Scleroderma | 0.000271442 | 1 | 0 | BeFree |
Morphologically altered structure | 0.000271442 | 1 | 0 | BeFree |
Collecting Duct Carcinoma of the Kidney | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma with neuroendocrine differentiation | 0.000271442 | 1 | 0 | BeFree |
Small cell glioblastoma | 0.000271442 | 1 | 0 | BeFree |
Primary cutaneous B-cell lymphoma | 0.000271442 | 1 | 0 | BeFree |
Storiform collagenoma | 0.000271442 | 1 | 0 | BeFree |
Single tumor | 0.000271442 | 1 | 0 | BeFree |
Eosinophilic disorder | 0.000271442 | 1 | 0 | BeFree |
Adenoid cystic breast carcinoma | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of ampulla of Vater | 0.000271442 | 1 | 0 | BeFree |
Cervical Endometrioid Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Flat Ductal Epithelial Atypia of the Breast | 0.000271442 | 1 | 0 | BeFree |
High Grade Cervical Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Meningeal Gliomatosis | 0.000271442 | 1 | 0 | BeFree |
Mucinous Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Spindle Cell Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Endometrial Endometrioid Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Differentiated Thyroid Gland Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Mixed Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Undifferentiated leukemia | 0.000271442 | 1 | 0 | BeFree |
Endometrial Cyst | 0.000271442 | 1 | 0 | BeFree |
Cardiomyopathy, Familial Idiopathic | 0.000271442 | 1 | 0 | BeFree |
Primary Glioblastoma | 0.000271442 | 1 | 0 | BeFree |
Prostate Basal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Serous Endometrial Intraepithelial Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Malignant Conversion | 0.000271442 | 1 | 0 | BeFree |
Tumor Expansion | 0.000271442 | 1 | 0 | BeFree |
Tumor Promotion | 0.000271442 | 1 | 0 | BeFree |
Type II Endometrial Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.000271442 | 1 | 0 | BeFree |
androgen independent prostate cancer | 0.000271442 | 1 | 0 | BeFree |
B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1 | 0.000271442 | 1 | 0 | BeFree |
Meningioma, benign, no ICD-O subtype | 0.000271442 | 1 | 0 | BeFree |
MULTICYSTIC RENAL DYSPLASIA, BILATERAL | 0.000271442 | 1 | 0 | BeFree |
Prostate Cancer, Hereditary, 7 | 0.000271442 | 1 | 0 | BeFree |
TUBEROUS SCLEROSIS 2 (disorder) | 0.000271442 | 1 | 0 | BeFree |
Angioma | 0.000271442 | 1 | 0 | BeFree |
Plasma Cell Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Philadelphia chromosome-positive acute lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
Urothelial Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Chronic kidney disease stage 2 | 0.000271442 | 1 | 0 | BeFree |
COWDEN-LIKE SYNDROME (disorder) | 0.000271442 | 1 | 0 | BeFree |
Steatohepatitis | 0.000271442 | 1 | 0 | BeFree |
Macroencephaly | 0.000271442 | 1 | 0 | BeFree |
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Cavernous Hemangioma of Brain | 0.000271442 | 1 | 0 | BeFree |
Prostate cancer, familial | 0.000271442 | 1 | 0 | BeFree |
Clear-cell metastatic renal cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
aggressive cancer | 0.000271442 | 1 | 0 | BeFree |
Vaginal Hemorrhage | 0.000271442 | 1 | 0 | BeFree |
Overgrowth Syndrome | 0.000271442 | 1 | 0 | BeFree |
vaginal bleeding during pregnancy | 0.000271442 | 1 | 0 | BeFree |
Ischemic Cerebrovascular Accident | 0.000271442 | 1 | 0 | BeFree |
Gastrointestinal Hamartoma | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。